IS4781A - Laktón afleiður af 17.beta.-karboxý, karbóþíó og amíð andróstan afleiður - Google Patents
Laktón afleiður af 17.beta.-karboxý, karbóþíó og amíð andróstan afleiðurInfo
- Publication number
- IS4781A IS4781A IS4781A IS4781A IS4781A IS 4781 A IS4781 A IS 4781A IS 4781 A IS4781 A IS 4781A IS 4781 A IS4781 A IS 4781A IS 4781 A IS4781 A IS 4781A
- Authority
- IS
- Iceland
- Prior art keywords
- derivatives
- carbothio
- 17beta
- carboxy
- amide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9526651.6A GB9526651D0 (en) | 1995-12-29 | 1995-12-29 | Compounds |
| GBGB9613121.4A GB9613121D0 (en) | 1996-06-21 | 1996-06-21 | Compounds |
| PCT/GB1996/003140 WO1997024365A1 (en) | 1995-12-29 | 1996-12-19 | Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS4781A true IS4781A (is) | 1998-06-23 |
Family
ID=26308402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4781A IS4781A (is) | 1995-12-29 | 1998-06-23 | Laktón afleiður af 17.beta.-karboxý, karbóþíó og amíð andróstan afleiður |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6197761B1 (is) |
| EP (1) | EP0876392B1 (is) |
| JP (1) | JP2947944B2 (is) |
| KR (1) | KR19990076859A (is) |
| CN (1) | CN1133643C (is) |
| AP (1) | AP9801274A0 (is) |
| AT (1) | ATE194356T1 (is) |
| AU (1) | AU721865B2 (is) |
| BG (1) | BG102625A (is) |
| BR (1) | BR9612309A (is) |
| CA (1) | CA2241728A1 (is) |
| CZ (1) | CZ207498A3 (is) |
| DE (1) | DE69609199T2 (is) |
| DK (1) | DK0876392T3 (is) |
| EA (1) | EA001401B1 (is) |
| EE (1) | EE9800227A (is) |
| ES (1) | ES2150150T3 (is) |
| GR (1) | GR3034564T3 (is) |
| HK (1) | HK1012193A1 (is) |
| HU (1) | HUP9903707A3 (is) |
| IL (1) | IL124938A0 (is) |
| IS (1) | IS4781A (is) |
| MX (1) | MX9805181A (is) |
| NO (1) | NO311022B1 (is) |
| NZ (1) | NZ324373A (is) |
| OA (1) | OA10701A (is) |
| PE (1) | PE87598A1 (is) |
| PL (1) | PL327629A1 (is) |
| PT (1) | PT876392E (is) |
| SI (1) | SI0876392T1 (is) |
| SK (1) | SK89198A3 (is) |
| TR (1) | TR199801247T2 (is) |
| TW (1) | TW498072B (is) |
| WO (1) | WO1997024365A1 (is) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE260931T1 (de) * | 1997-06-30 | 2004-03-15 | Glaxo Group Ltd | Verfahren zur identifizierung von verbindungen mit verminderter systemischer aktivität |
| GB9909229D0 (en) * | 1999-04-23 | 1999-06-16 | Glaxo Group Ltd | Enantiomers of mercapto lactones and processes for their synthesis |
| GB0017988D0 (en) * | 2000-07-21 | 2000-09-13 | Glaxo Group Ltd | Novel process |
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6759398B2 (en) | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| US6787532B2 (en) | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| SK287576B6 (sk) * | 2000-08-05 | 2011-03-04 | Glaxo Group Limited | S-fluórmetylester kyseliny 6alfa, 9alfa-difluór-17alfa-[(2- furanylkarboxyl)oxy]-11beta-hydroxy-16alfa-metyl-3-oxo-androsta- 1,4-dién-17beta-karbotiovej, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom, jeho použitie a medziprodukty |
| US6750210B2 (en) | 2000-08-05 | 2004-06-15 | Smithkline Beecham Corporation | Formulation containing novel anti-inflammatory androstane derivative |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6777400B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6858593B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| UA77656C2 (en) | 2001-04-07 | 2007-01-15 | Glaxo Group Ltd | S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent |
| AR033290A1 (es) * | 2001-04-30 | 2003-12-10 | Glaxo Group Ltd | Derivados antiinflamatorios de androstano |
| WO2002100879A1 (en) * | 2001-06-12 | 2002-12-19 | Glaxo Group Limited | Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| WO2003018575A1 (en) * | 2001-08-24 | 2003-03-06 | Wyeth Holdings Corporation | 5-substituted-3(2h)-furanones useful for inhibition of farnesyl-protein transferase |
| GB0125259D0 (en) | 2001-10-20 | 2001-12-12 | Glaxo Group Ltd | Novel compounds |
| WO2003042229A1 (en) * | 2001-11-12 | 2003-05-22 | Glaxo Group Limited | Non-aromatic heterocyclic esters of furan-2-one-esters of 17.beta.-carboxyl or 17.beta.-carbothio glucocorticoids |
| GB0127160D0 (en) * | 2001-11-12 | 2002-01-02 | Glaxo Group Ltd | Novel compounds |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| EP1466920A1 (en) * | 2003-04-04 | 2004-10-13 | Alpharma APS | Process for the preparation of steroidal 17 beta-carbothioates |
| JP2006522028A (ja) * | 2003-04-04 | 2006-09-28 | アルファーマ エーピーエス | ステロイド性カルボチオ酸誘導体の製造方法および中間体 |
| PT103202B (pt) | 2004-10-19 | 2011-01-27 | Hovione Farmaciencia S A | Processo para a esterificação de um ácido carbotiótico |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| AR059216A1 (es) * | 2006-01-27 | 2008-03-19 | Sun Pharmaceutical Ind Ltd | 11b-hidroxiandrosta-4-eno-3-onas |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| CN103087137A (zh) * | 2011-11-07 | 2013-05-08 | 天津金耀集团有限公司 | 一种21位为硫代烃基的糖皮质激素 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4093721A (en) * | 1974-08-30 | 1978-06-06 | Glaxo Laboratories Limited | Pharmaceutical compositions of 6α,9α-difluoro-androst-4-ene-17β-carboxylates and derivatives thereof |
| US4188385A (en) | 1978-04-05 | 1980-02-12 | Syntex (U.S.A.) Inc. | Thioetianic acid derivatives |
| SE8306370D0 (sv) | 1983-11-18 | 1983-11-18 | Draco Ab | Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions |
| IL78144A0 (en) | 1985-04-04 | 1986-07-31 | Draco Ab | Novel androstane-17beta-carboxylic acid esters |
| US5767113A (en) * | 1995-05-10 | 1998-06-16 | The Salk Institute For Biological Studies | Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
-
1996
- 1996-12-19 EP EP96942493A patent/EP0876392B1/en not_active Expired - Lifetime
- 1996-12-19 CZ CZ982074A patent/CZ207498A3/cs unknown
- 1996-12-19 ES ES96942493T patent/ES2150150T3/es not_active Expired - Lifetime
- 1996-12-19 DE DE69609199T patent/DE69609199T2/de not_active Expired - Fee Related
- 1996-12-19 US US09/091,748 patent/US6197761B1/en not_active Expired - Fee Related
- 1996-12-19 HU HU9903707A patent/HUP9903707A3/hu unknown
- 1996-12-19 KR KR1019980704986A patent/KR19990076859A/ko not_active Application Discontinuation
- 1996-12-19 AP APAP/P/1998/001274A patent/AP9801274A0/en unknown
- 1996-12-19 CN CNB961801077A patent/CN1133643C/zh not_active Expired - Lifetime
- 1996-12-19 NZ NZ324373A patent/NZ324373A/en unknown
- 1996-12-19 PL PL96327629A patent/PL327629A1/xx unknown
- 1996-12-19 EE EE9800227A patent/EE9800227A/xx unknown
- 1996-12-19 DK DK96942493T patent/DK0876392T3/da active
- 1996-12-19 EA EA199800484A patent/EA001401B1/ru not_active IP Right Cessation
- 1996-12-19 JP JP9524095A patent/JP2947944B2/ja not_active Expired - Fee Related
- 1996-12-19 PT PT96942493T patent/PT876392E/pt unknown
- 1996-12-19 AT AT96942493T patent/ATE194356T1/de not_active IP Right Cessation
- 1996-12-19 TR TR1998/01247T patent/TR199801247T2/xx unknown
- 1996-12-19 IL IL12493896A patent/IL124938A0/xx unknown
- 1996-12-19 CA CA002241728A patent/CA2241728A1/en not_active Abandoned
- 1996-12-19 AU AU11409/97A patent/AU721865B2/en not_active Ceased
- 1996-12-19 WO PCT/GB1996/003140 patent/WO1997024365A1/en not_active Application Discontinuation
- 1996-12-19 SK SK891-98A patent/SK89198A3/sk unknown
- 1996-12-19 SI SI9630232T patent/SI0876392T1/xx unknown
- 1996-12-19 BR BR9612309A patent/BR9612309A/pt not_active Application Discontinuation
-
1997
- 1997-06-26 TW TW086108975A patent/TW498072B/zh active
- 1997-06-27 PE PE1997000549A patent/PE87598A1/es not_active Application Discontinuation
-
1998
- 1998-06-19 OA OA9800089A patent/OA10701A/en unknown
- 1998-06-23 IS IS4781A patent/IS4781A/is unknown
- 1998-06-25 MX MX9805181A patent/MX9805181A/es unknown
- 1998-06-26 NO NO19983004A patent/NO311022B1/no not_active IP Right Cessation
- 1998-07-13 BG BG102625A patent/BG102625A/xx unknown
- 1998-12-16 HK HK98113683A patent/HK1012193A1/xx not_active IP Right Cessation
-
2000
- 2000-10-04 GR GR20000402254T patent/GR3034564T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS4781A (is) | Laktón afleiður af 17.beta.-karboxý, karbóþíó og amíð andróstan afleiður | |
| LV11739A (lv) | Eritromicina atvasinajumi iegusanas panemiens un pielietojums | |
| NO305833B1 (no) | Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene | |
| NL300214I1 (nl) | Chinazolinederivaten. | |
| DE122009000076I1 (de) | Chinazolin-derivate | |
| PT1000048E (pt) | Derivados substituidos do 1,2,3,4-tetrahidronaftaleno | |
| TR199600177A2 (tr) | N-(3-benzofuranil)üre türevleri. | |
| NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
| NO961346D0 (no) | Benzonitriler og benzofluorider | |
| PT921125E (pt) | Derivados de 1,38-triaza-espiro 4,5 decan-4-ona | |
| NO20013237D0 (no) | 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater | |
| ATA100695A (de) | Prothrombin-derivate | |
| TR199600715A2 (tr) | Kefalosforin türevleri. | |
| DK0821692T3 (da) | Immunopotenserende inosinmonophosphat-5'-nukleotidasemodstandsdygtige derivater og anvendelser deraf | |
| DE69613074T2 (de) | Pasteureinrichtung | |
| TR199600064A2 (tr) | 4-amino-benzoilguanidin-türevleri. | |
| NO964684D0 (no) | 2-(aminometyl)-3,4,7,9-tetrahydro-2H-pyrano-[2,3-eÅ indol-8-oner og derivater | |
| DE59610106D1 (de) | Fluorbenzylether-Derivate | |
| ATE225347T1 (de) | Aza-anthracyclinone-derivate | |
| DE59607055D1 (de) | 4-Mercapto-benzoylguanidin-Derivate | |
| PT796843E (pt) | Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol | |
| NO973624D0 (no) | Vasokonstriktive substituerte 2,3-dihydro-1,4-dioksinopiperidiner | |
| DK0810216T3 (da) | Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid | |
| NO962931D0 (no) | N,N-Dietyl-8,8-dipropyl-2-azaspiro[4,5Ådecan-2-propanamindimaleat | |
| ATA45796A (de) | Lysin-prolin-derivate |